Olstein Capital Management L.P. Trims Stake in First Advantage Co. (NYSE:FA)

Olstein Capital Management L.P. lessened its stake in First Advantage Co. (NYSE:FA) by 4.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 63,000 shares of the company’s stock after selling 3,000 shares during the period. Olstein Capital Management L.P.’s holdings in First Advantage were worth $1,180,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in FA. Quarry LP increased its stake in shares of First Advantage by 49.7% in the 2nd quarter. Quarry LP now owns 2,607 shares of the company’s stock valued at $42,000 after purchasing an additional 865 shares in the last quarter. Intech Investment Management LLC acquired a new stake in First Advantage in the third quarter valued at approximately $250,000. Marshall Wace LLP purchased a new stake in shares of First Advantage in the second quarter valued at approximately $209,000. Brighton Jones LLC acquired a new position in shares of First Advantage during the 4th quarter worth approximately $257,000. Finally, Truist Financial Corp purchased a new position in shares of First Advantage during the 2nd quarter valued at approximately $234,000. Institutional investors and hedge funds own 94.91% of the company’s stock.

First Advantage Price Performance

FA stock opened at $18.48 on Friday. First Advantage Co. has a 1 year low of $14.01 and a 1 year high of $20.79. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.85 and a quick ratio of 3.85. The firm has a market capitalization of $3.19 billion, a PE ratio of 616.00 and a beta of 1.17. The business has a 50 day simple moving average of $18.74 and a 200-day simple moving average of $18.49.

First Advantage (NYSE:FA) last issued its earnings results on Tuesday, November 12th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.01. The company had revenue of $199.10 million during the quarter, compared to analysts’ expectations of $204.39 million. First Advantage had a return on equity of 13.16% and a net margin of 0.65%. The firm’s quarterly revenue was down .6% on a year-over-year basis. During the same period in the prior year, the business earned $0.25 EPS. Equities research analysts anticipate that First Advantage Co. will post 0.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on FA shares. Barclays restated an “overweight” rating and set a $22.00 price objective on shares of First Advantage in a research report on Wednesday, November 20th. William Blair restated an “outperform” rating on shares of First Advantage in a research report on Wednesday, December 11th. Royal Bank of Canada reiterated an “outperform” rating and issued a $22.00 price objective on shares of First Advantage in a report on Thursday. Needham & Company LLC reissued a “hold” rating on shares of First Advantage in a report on Wednesday, November 13th. Finally, BMO Capital Markets assumed coverage on First Advantage in a research note on Wednesday, December 11th. They issued an “outperform” rating and a $20.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $53.29.

About First Advantage

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.